文献速递心境障碍精神分裂症与精神病性障碍会诊联络精神医学

重性精神疾病患者心血管疾病患病率、发病率与死亡率的大规模荟萃分析

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.
PubMed 文献 · World Psychiatry · 2017-01-01

该研究纳入92项研究、3,211,768例重性精神疾病患者与113,383,368例对照,评估心血管疾病患病、发病及死亡风险。结果显示患者心血管疾病患病率9.9%,横断面研究OR=1.53,纵向研究HR=1.78,心血管相关死亡HR=1.85,提示需 urgent 临床关注。

要点

  • 重性精神疾病患者心血管疾病患病率9.9%,发病及死亡风险显著高于对照。
  • 抗精神病药使用、较高BMI与心血管疾病发病率升高相关。
  • 需紧急关注重性精神疾病患者的心血管筛查与管理。

核心结论

  • 重性精神疾病患者心血管疾病患病、发病及心血管相关死亡风险显著增加。
  • 较高BMI、抗精神病药使用及心血管筛查与管理需紧急临床关注。

研究设计与样本

  • 大规模荟萃分析,纳入92项研究,重性精神疾病患者N=3,211,768,对照N=113,383,368。
  • 评估患病率、发病率及心血管疾病相关死亡,包括冠心病、脑血管病、充血性心力衰竭等。

主要发现

  • 重性精神疾病患者(平均年龄50岁)汇总心血管疾病患病率为9.9%(95%CI:7.4-13.3)。
  • 横断面研究中,校正中位7个混杂因素后,患者心血管疾病OR=1.53(95%CI:1.27-1.83;11项研究)。
  • 纵向研究中,中位随访8.4年(范围1.8-30.0),累积心血管疾病发病率为3.6%(95%CI:2.7-5.3)。
  • 校正中位6个混杂因素后,患者心血管疾病发病HR=1.78(95%CI:1.60-1.98;31项研究)。
  • 心血管疾病相关死亡HR=1.85(95%CI:1.53-2.24);重性抑郁、双相障碍和精神分裂症患者风险均增加。

关键数值与推荐

  • 冠心病OR=1.51(95%CI:1.47-1.55),脑血管病OR=1.42(95%CI:1.21-1.66)。
  • 冠心病发病HR=1.54(95%CI:1.30-1.82),脑血管病HR=1.64(95%CI:1.26-2.14),充血性心力衰竭HR=2.10(95%CI:1.64-2.70)。
  • 心血管疾病发病率随抗精神病药使用(p=0.008)、较高BMI(p=0.008)及较高基线心血管疾病患病率(p=0.03)增加。
  • 心血管疾病患病率(p=0.007)在较近期研究中增加,但发病率(p=0.21)未增加。

临床怎么用

  • 对重性精神疾病患者应常规筛查和管理心血管疾病风险。
  • 关注抗精神病药使用及体重管理,以降低心血管疾病发病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: People with severe mental illness (SMI) - schizophrenia, bipolar disorder and major depressive disorder - appear at risk for cardiovascular disease (CVD), but a comprehensive meta-analysis is lacking. We conducted a large-scale meta-analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD-related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4-13.3). Adjusting for a median of seven confounders, patients had significantly higher odds of CVD versus controls in cross-sectional studies (odds ratio, OR=1.53, 95% CI: 1.27-1.83; 11 studies), and higher odds of coronary heart disease (OR=1.51, 95% CI: 1.47-1.55) and cerebrovascular disease (OR=1.42, 95% CI: 1.21-1.66). People with major depressive disorder were at increased risk for coronary heart disease, while those with schizophrenia were at increased risk for coronary heart disease, cerebrovascular disease and congestive heart failure. Cumulative CVD incidence in SMI patients was 3.6% (95% CI: 2.7-5.3) during a median follow-up of 8.4 years (range 1.8-30.0). Adjusting for a median of six confounders, SMI patients had significantly higher CVD incidence than controls in longitudinal studies (hazard ratio, HR=1.78, 95% CI: 1.60-1.98; 31 studies). The incidence was also higher for coronary heart disease (HR=1.54, 95% CI: 1.30-1.82), cerebrovascular disease (HR=1.64, 95% CI: 1.26-2.14), congestive heart failure (HR=2.10, 95% CI: 1.64-2.70), and CVD-related death (HR=1.85, 95% CI: 1.53-2.24). People with major depressive disorder, bipolar disorder and schizophrenia were all at increased risk of CVD-related death versus controls. CVD incidence increased with antipsychotic use (p=0.008), higher body mass index (p=0.008) and higher baseline CVD prevalence (p=0.03) in patients vs. CONTROLS: Moreover, CVD prevalence (p=0.007), but not CVD incidence (p=0.21), increased in more recently conducted studies. This large-scale meta-analysis confirms that SMI patients have significantly increased risk of CVD and CVD-related mortality, and that elevated body mass index, antipsychotic use, and CVD screening and management require urgent clinical attention.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017. PMID: 28498599. doi:10.1002/wps.20420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。